Literature DB >> 23504604

Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery.

Prithivi Raj1, Lileswar Kaman, Rajinder Singh, Divya Dahyia, Anish Bhattacharya, Amanjit Bal.   

Abstract

18F-Fluorodeoxyglucose-positron emission tomography/computerised tomography (FDG-PET/CT) was investigated for evaluation of periampullary tumours and other gastrointestinal neoplasms. The aim of this study was to evaluate the utility of FDG-PET/CT for detection of lymph node metastasis in periampullary tumours by comparing the preoperative FDG-PET/CT scan finding with postoperative histopathology of lymph nodes. Study was done on 24 patients with diagnosis of periampullary carcinoma either proven or suspected on conventional radiology. Standard uptake value (SUV) were measured for lymph node areas with uptake in FDG-PET/CT and compared with histopathological lymph node status. For detection of lymph node metastasis, FDG-PET/CT with cutoff value SUV max ≥2.0 had a sensitivity of 71.4 % and specificity of 77.8 % and that for SUV max ≥2.5 and 2.8 were 57.1, 42.9 and 77.8, 77.8 %, respectively. The sensitivity and specificity of FDG-PET/CT at each lymph node groups were 72 and 89 % in peripancreatic area, 100 and 93 % in hepatoduodenal area and 100 and 100 % in aortocaval area at SUV max ≥2.0, respectively. At SUV max ≥2.5 the values were 57 and 89 % in peripancreatic area, 100 and 93 % in hepatoduodenal area and 100 and 93 % in aortocaval area. FDG-PET-CT has a possible role in detection of lymph node metastasis in periampullary carcinomas and may be used as a guide for possible lymphadenectomy during surgery and for prognostic purpose.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23504604     DOI: 10.1007/s13304-013-0205-4

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  12 in total

1.  Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses.

Authors:  C G Diederichs; L Staib; J Vogel; B Glasbrenner; G Glatting; H J Brambs; H G Beger; S N Reske
Journal:  Pancreas       Date:  2000-03       Impact factor: 3.327

2.  Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.

Authors:  Cosimo Sperti; Claudio Pasquali; Vittorio Fiore; Sergio Bissoli; Franca Chierichetti; Guido Liessi; Sergio Pedrazzoli
Journal:  Am J Surg       Date:  2006-06       Impact factor: 2.565

3.  The role of laparoscopy in the preoperative staging of pancreatic carcinoma.

Authors:  B Rumstadt; M Schwab; K Schuster; E Hagmüller; M Trede
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

Review 4.  Periampullary cancers: are there differences?

Authors:  J M Sarmiento; D M Nagomey; M G Sarr; M B Farnell
Journal:  Surg Clin North Am       Date:  2001-06       Impact factor: 2.741

5.  Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms.

Authors:  Matthew F Kalady; Bryan M Clary; Lisa A Clark; Marcia Gottfried; Eric M Rohren; R Edward Coleman; Theodore N Pappas; Douglas S Tyler
Journal:  Ann Surg Oncol       Date:  2002-10       Impact factor: 5.344

6.  PET and PET/CT for pancreatic malignancies.

Authors:  Dominique Delbeke; William H Martin
Journal:  Surg Oncol Clin N Am       Date:  2010-04       Impact factor: 3.495

7.  Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Authors:  Veerle Casneuf; Louke Delrue; Annemarie Kelles; Nancy Van Damme; Jacques Van Huysse; Frederik Berrevoet; Martine De Vos; Philippe Duyck; Marc Peeters
Journal:  Acta Gastroenterol Belg       Date:  2007 Oct-Dec       Impact factor: 1.316

8.  18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Cosimo Sperti; Sergio Bissoli; Claudio Pasquali; Laura Frison; Guido Liessi; Franca Chierichetti; Sergio Pedrazzoli
Journal:  Ann Surg       Date:  2007-12       Impact factor: 12.969

9.  Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Authors:  C J Yeo; J L Cameron; K D Lillemoe; J V Sitzmann; R H Hruban; S N Goodman; W C Dooley; J Coleman; H A Pitt
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  8 in total

Review 1.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

2.  Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.

Authors:  Kyoung-Min Cho; Do-Youn Oh; Tae-Yong Kim; Kyung Hun Lee; Sae-Won Han; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang
Journal:  Oncologist       Date:  2015-06-22

3.  Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma.

Authors:  Pei-Ju Chuang; Hsiu-Po Wang; Yu-Jen Lin; Chieh-Chang Chen; Yu-Wen Tien; Min-Shu Hsieh; Shih-Hung Yang; Ruoh-Fang Yen; Chi-Lun Ko; Yen-Wen Wu; Mei-Fang Cheng
Journal:  Eur Radiol       Date:  2021-04-17       Impact factor: 5.315

4.  Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.

Authors:  Hye Jin Choi; Chang Moo Kang; Kwanhyeong Jo; Woo Jung Lee; Jae-Hoon Lee; Young Hoon Ryu; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-13       Impact factor: 9.236

5.  Combining endoscopic ultrasound and tumor markers improves the diagnostic yield on the etiology of common bile duct dilation secondary to periampullary pathologies.

Authors:  Han Ding; Pinghong Zhou; Meidong Xu; Weifeng Chen; Quanlin Li; Tao Chen; Mingyan Cai; Tianyin Chen; Jingjing Lian; Yiqun Zhang
Journal:  Ann Transl Med       Date:  2019-07

6.  Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.

Authors:  Stefanie M F Seiler; Christine Baumgartner; Johannes Hirschberger; Ambros J Beer; Andreas Brühschwein; Nina Kreutzmann; Silja Laberke; Melanie C Wergin; Andrea Meyer-Lindenberg; Johanna Brandl; Anne-Kathrin von Thaden; Eliane Farrell; Markus Schwaiger
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

7.  A CT-Based Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Periampullary Carcinomas.

Authors:  Lei Bi; Yubo Liu; Jingxu Xu; Ximing Wang; Tong Zhang; Kaiguo Li; Mingguang Duan; Chencui Huang; Xiangjiao Meng; Zhaoqin Huang
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

8.  Evaluation of the clinical and economic impact of delays to surgery in patients with periampullary cancer.

Authors:  R Pandé; J Hodson; A Murray; F Marcon; M Kalisvaart; R Marudanayagam; R P Sutcliffe; D F Mirza; J Isaac; K J Roberts
Journal:  BJS Open       Date:  2019-04-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.